This message includes updates on the COVID-19 response from CDC. This is a rapidly evolving situation and information will be updated as it becomes available.

Received this email from a friend? Sign up now

View this email in your web browser

January 9, 2023 This message includes updates on the COVID-19 response from CDC. The COVID-19 Outbreak is a rapidly evolving situation and information will be updated as it becomes available.

Two Years of COVID-19 Vaccination December 2022 marked two years since the first COVID-19 vaccine was administered in the U.S. Although too many lives have been lost to COVID-19 since the start of the pandemic, vaccination has helped prevent millions of hospitalizations and saved millions of lives. Stay up to date on your vaccines to protect yourselves, your loved ones, and your community against COVID-19. As with other vaccine-preventable diseases, you are protected best from COVID-19 when you stay up to date with the recommended vaccinations, including recommended boosters.

Get an updated bivalent booster at least 2 months after completing your primary series or last booster. If you’ve had COVID-19, you may delay getting your booster by 3 months since your symptoms ended.

Learn More

Flu Vaccine and COVD-19 Boosters Studies conducted throughout the COVID-19 pandemic indicate that it is safe to get both a flu vaccine and a COVID-19 vaccine at the same visit. A CDC study published last summer showed people who got a flu vaccine and a COVID-19 booster vaccine at the same time were slightly more likely to have reactions including fatigue, headache, and muscle ache than people who only got a COVID-19 booster vaccine, but these reactions were mostly mild and went away quickly. The findings of this study are similar to safety data from clinical trials that did not find any safety concerns with giving both vaccines at the same time.

To find COVID-19 vaccine locations near you, visit vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233.

Learn More

Ensuring COVID-19 Vaccine Safety To make sure that COVID-19 vaccines are safe, CDC expanded and strengthened the country’s ability to monitor vaccine safety. CDC created new web-based platforms to gather information and give CDC scientists information about the safety of COVID-19 vaccines in real time. As a result, vaccine safety experts can monitor and detect issues that may not have been seen during the COVID-19 vaccine clinical trials. If any vaccine safety issues—also called adverse events— are reported, CDC scientists can quickly study them and determine if there is a safety concern with a particular vaccine.

Learn More

COVID Data Tracker Weekly Review The most recent Omicron sublineage, XBB.1.5, is on the rise across the United States. Projections can be uncertain when a variant is just beginning to spread, and CDC is continuing to investigate the ways in which XBB.1.5 may be different from other Omicron lineages. This week’s COVID Data Tracker Weekly Review explains weighted estimates and Nowcast estimates, the two methods CDC uses to display variant proportions. Learn More Subscribe

COVID-19 Community Levels

CDC uses COVID-19 Community Levels to determine the disease’s impact on counties and recommend prevention measures. CDC also tracks cases, laboratory tests, vaccinations, deaths, and other pandemic data and provides them on our COVID Data Tracker.

Community Levels

Centers for Disease Control and Prevention 1600 Clifton Rd   Atlanta, GA 30329   1-800-CDC-INFO (800-232-4636)   TTY: 888-232-6348 Questions or Problems  |  Unsubscribe

The COVID-19 Vaccine Delivery Partnership | Update (December 2022)

An update from the COVID-19 Vaccine Delivery Partnership ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

No images? Click here Subscribe December 2022 | Issue 04   A responsibility of our lifetime Vaccine Equity for COVID-19 vaccination is not just the final mile. It is the way to help make things right towards health equity. There are bottlenecks to resolve, supply chains to link up, and health workers to adequately resource. It is a responsibility of a lifetime.     COVID-19 Vaccine Delivery Partnership Situation Report This report covers the month of November 2022.  In this edition: Overview: Global Situation | 92 Advance Market Commitment Countries | 34 countries for concerted support  In-depth: Integration of COVID-19 vaccinations into immunization programmes and primary health care  Country insights: Somalia and Sudan     COVID-19 Vaccine Delivery News and Stories In Niger, community leaders fight rumours about COVID-19 vaccines In his palace facing one of the main public squares of the city, Sani Touraki, representative of the Sultanate of Katsina, receives visitors in his courtyard. Like other community leaders in the Maradi region, he is approached by the health authorities before each COVID-19 vaccination campaign to help alleviate reluctance among the population. Read more En RDC, les populations déplacées internes du Tanganyika bénéficient de la vaccination contre la COVID-19 grâce au financement de l’Union européenne Women at the forefront of Yemen's healthcare response to COVID-19 2022 was a wake-up call for global health. Let's turn the tide in 2023 Self-financing COVAX champions: Lebanon CARE Iraq Leads COVID-19 Vaccination Campaigning Door-to-door visits to boost vaccination rates   Resources, Reports and Technical Guidance NEW:  COVAX: Structure and Principles This document outlines the working structure and guiding principles for collaboration of COVAX, the Vaccines pillar of the Access to COVID-19 Tools Accelerator (ACT-A). The working structure of COVAX continues to adapt to emerging needs and the changing trajectory of the pandemic.  NEW:  ACT-Accelerator Outcomes Report, 2020-22 This report provides information on cumulative achievements of the ACT-Accelerator partnership since the start of the pandemic to end September 2022, an account of the outcomes of the four Pillars’ work towards the milestones set out in the 2021-22 Strategic Plan, and incorporates the regular Q3 Update. NEW:  Update on the rollout of COVID-19 tools: a report from the ACT-A Tracking & Monitoring Task Force This report is an outcome of the first meeting of the ACT-Accelerator Tracking and Monitoring Taskforce, held on 9th December 2022. This new taskforce – co-chaired by India and the United States – continues key elements of the work of the Facilitation Council and its working groups. NEW:  Country experiences with COVID-19 vaccination: Mainstreaming & integration with immunization programme services and PHC Presentation with country examples of good practices and innovation to mainstream/integrate COVID-19 vaccination in the main critical areas of vaccination. Considerations to inform country COVID-19 vaccine decision-making This slide set summarizes WHO latest recommendations on COVID-19 vaccines and considerations for current and future COVID-19 vaccination. The objective is to help orient the Ministry of Health (MoH) and National Immunization Advisory Committee Group (NITAG) in their COVID-19 vaccine strategic decisions WHO – UNICEF guidance: Considerations for integrating COVID-19 vaccination into immunization programmes and primary health care for 2022 and beyond English | French | Spanish | Portuguese   All COVID-19 vaccine delivery resources Global Compendium of country knowledge on COVID-19 vaccination All WHO COVID-19 vaccine resources: toolkit All WHO COVID-19 technical guidance AR EN ES FR RU ZH      Conferences and trainings NEW: "Empowering Health Workers to Build Public Trust in Vaccination: Experience from the International Pediatric Association’s Online Vaccine Trust Course, 2020–2021" has been published in the Vaccine Journal.   Call for abstracts Vaccine Acceptance Research Network Conference UNICEF is partnering with Sabin to announce the second annual Vaccination Acceptance Research Network conference, VARN2023, will be held from June 13-15, 2023, in Bangkok, Thailand. This meeting will be an open, in-person event with facilitation of virtual presentations, as needed. Conference sessions will provide a space for exploration and facilitate the wide dissemination of a growing body of knowledge, practice, and evidence-informed strategies for driving action across the vaccination acceptance and demand ecosystem.  Submission Deadline: January 13, 2023 11:59pm EST. You can apply in either English or in French.     Learning Collective Initiative in Covid-19 Vaccine Delivery Partnership This initiative series aims to collect and share key learnings, best practices and challenges in planning and implementing COVID-19 vaccination uptake. The sessions cover a range of topics with the November session focusing on best practices to integrate Covid-19 vaccination into Primary Health Care and Essential Immunization. Two countries presented their experiences: Cambodia (integrating Covid-19 vaccination with hypertension and diabetes screening for adults) and Colombia (joint planning of Covid-19 vaccine as one more vaccine of the National Immunization Program for 2023). Slides and recordings from past sessions as well as registration links for future sessions are available here. For more information on the topic of integration, see: Country experiences to date on integrating C-19 vaccination     Consultancy: Manager, Country Communications An opportunity to work with the COVID-19 Vaccine Delivery, Coordination and Integration team at Gavi. The team facilitates a country-driven approach to COVID-19 stakeholder engagement. Please apply if you are a strong project manager, relationship builder and communicator. More       You are receiving this because you have subscribed to receive updates from WHO, UNICEF or GAVI on COVID-19 vaccines, vaccine equity or vaccine delivery. You can unsubscribe via the link below. You will be unsubscribed from this update only. Other subscriptions you may have with WHO, UNICEF or GAVI will not be changed.         COVID-19 Vaccine Delivery Partnership, Global Health Campus, Geneva, Switzerland Preferences  |  Unsubscribe